Non Hodgkin's lymphomas: prognostic feature of 55 patients treated with MEVAP chemotherapy
Mazza, P.; Lauria, F.; Gherlinzoni, F.; Fiacchini, M.; Galieni, P.; Tura, S.
Haematologica 69(2): 178-187
1984
ISSN/ISBN: 0390-6078 PMID: 6429003 Document Number: 226262
Document emailed within 1 workday
Related Documents
De Kreuk, M.; Ossenkoppele, G.J.; Meijer, C.J.; Huijgens, P.C. 1996: Prognostic factors for survival of non-Hodgkin's lymphoma patients treated with high-dose chemotherapy and autologous bone marrow transplantation Bone Marrow Transplantation 17(6): 963-971Oriol, A.; Ribera, J.M.; Flores, A.; Batlle, M.; las Heras, G.; Vaquero, M.; Juncá, J.; Millá, F.; Feliu, E. 1995: Primary extralymphatic non-Hodgkin's lymphomas: the response to treatment and prognostic factors in 73 patients Medicina Clinica 104(8): 281-286
Plat, M.; Fleischer, J.; Hermann, T.; Plat, U.; Lesche, A.; Föse, E.M.; Wolf, H.; Reinhardt, U. 1989: Non-Hodgkin's lymphomas--prognostic analysis and therapeutic recommendations Acta Haematologica Polonica 20(1): 1-7
Coiffier, B. 1993: Prognostic factors in non-Hodgkin's lymphomas. Therapeutic implications La Revue du Praticien 43(13): 1640-1643
Pereira, A.; Montserrat, E. 1988: Non-Hodgkin's lymphomas: importance of prognostic factors in therapeutic decisions Medicina Clinica 91(5): 172-174
Mott, M.G. 1981: Combination chemotherapy of childhood non-Hodgkin's lymphomas Cancer Treatment Reports 65(Suppl 1): 119-123
Fülle, H.H.; Pribilla, W. 1980: Kiel classification of non-Hodgkin lymphomas: diagnostic aspects and prognostic relevance Haematologica 65(1): 96-106
Serrano, J.C.; Contreras, K.; Insausti, L.; Figueroa, L.; Acquatella, G. 1999: Thyroid complications in Hodgkin's disease patients treated with radiotherapy and chemotherapy Sangre 44(6): 496-497
Vassilakopoulos, T.P.; Nadali, G.; Angelopoulou, M.K.; Dimopoulou, M.N.; Siakantaris, M.P.; Kontopidou, F.N.; Karkantaris, C.; Kokoris, S.I.; Dimitriadou, E.M.; Calpadaki, C.; Sarantopoulos, A.; Galani, Z.; Sachanas, S.; Kyrtsonis, M.C.; Tsaftaridis, P.; Variamis, E.; Panayotidis, P.; Pizzolo, G.; Sarris, A.H.; Pangalis, G.A. 2005: Beta(2)-microglobulin in Hodgkin's lymphoma: prognostic significance in patients treated with ABVD or equivalent regimens Journal of BUON: Official Journal of the Balkan Union of Oncology 10(1): 59-69
Meuthen, I.; Mödder, B. 1981: Advanced non-Hodgkin lymphomas in adults. Cytostatic chemotherapy Die Medizinische Welt 32(41): 1545-1547
Bacci, G.; Picci, P.; Bertoni, F.; Gherlinzoni, F.; Calderoni, P.; Campanacci, M. 1982: Primary non-Hodgkin's lymphoma of bone: results in 15 patients treated by radiotherapy combined with systemic chemotherapy Cancer Treatment Reports 66(10): 1859-1862
Lackowska, B.; Gruchała, A.; Niezabitowski, A.; Radkowski, A.; Skołyszewski, J.; Ryś, J.; Szklarski, W.; Sokołowski, A. 1999: Prognostic and predictive evaluation of DNA content, S-phase fraction and immunophenotyping in non-Hodgkin's lymphomas in adults. A prospective study Polish Journal of Pathology: Official Journal of the Polish Society of Pathologists 50(1): 23-29
Mandelli, F.; Biagini, C.; Baroni, C.D.; Bosman, C.; Alimena, G.; Anselmo, A.P.; De Luca, A.M.; Maurizi Enrici, R.; Petti, N.; Amadori, S.; Papa, G. 1981: Combination chemotherapy of unfavourable prognosis non-Hodgkin's lymphomas (NHL). A retrospective study of 53 cases Haematologica 66(6): 740-749
Heinz, R.; Pawlicki, M.; Losonczy, H.; Varbiro, M.; Benedek, S.; Konopka, L.; Krc, I.; Brugiatelli, M. 1986: Initial chemotherapy with an age-adjusted CHOP-schedule in non-Hodgkin lymphomas with unfavorable prognosis. a study of the I.G.C.i Haematologica 71(6): 473-479
Takagi, T.; Sakai, C.; Oguro, M. 1993: Alternating CHOP-MEVP chemotherapy for advanced-stage, intermediate- and high-grade non-Hodgkin's lymphomas Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(14): 2191-2194
Huo, Y.Ruth.; Huang, Y.; Liauw, W.; Zhao, J.; Morris, D.L. 2016: Prognostic Value of Carcinoembryonic Antigen (CEA), AFP, CA19-9 and CA125 for Patients with Colorectal Cancer with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy Anticancer Research 36(3): 1041-1049
Inaji, H.; Noguchi, S.; Yamamoto, H.; Koyama, H.; Iwanaga, T.; Wada, A. 1989: Analysis of prognostic factors in patients with locally advanced breast cancer treated with intra-arterial infusion chemotherapy as an induction therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(8 Part 2): 2910-2912
Villani, F.; Dell'Oca, I.; De Maria, P.; Viola, G.; Di Russo, A.; Viviani, S.; Bonfante, V. 1999: Lung function and serum concentration of tumor necrosis factor-alpha, interleukin-6 and fibronectin in patients treated with ABVD chemotherapy followed by radiotherapy for mediastinal Hodgkin's disease Anticancer Research 19(5c): 4475-4479
Crvenkova, S.; Pesevska, M. 2015: Important prognostic factors for the long-term survival in non-small cell lung cancer patients treated with combination of chemotherapy and conformal radiotherapy Journal of Buon: Official Journal of the Balkan Union of Oncology 20(3): 775-781
Nikolic, S.; Dzodic, R.; Zegarac, M.; Djurisic, I.; Gavrilovic, D.; Vojinovic, V.; Kocic, M.; Santrac, N.; Radlovic, P.; Radosavljevic, D.; Pupic, G.; Martinovic, A. 2014: Survival prognostic factors in patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy: a single institution experience Journal of BUON: Official Journal of the Balkan Union of Oncology 19(1): 66-74